Zhao et al. [15] reported down-regulation of HLA class I genes (which comprise HLA-A, HLA-B, or HLA-C) on CD4(+) and on CD8(+) T lymphocytes in breast cancer patients when as compared with healthy controls. The gene discussed is HLA-C; the disease is breast carcinoma.